PALISADE BIO INC

Insider buying at Palisade Bio signals confidence in its rising GI‑therapeutics pipeline, hinting at future upside for investors.

Insider buying at Palisade Bio shows leadership confidence amid volatility, signaling potential future upside for long‑term investors.

Insider buying at Palisade Bio shows confidence amid volatility, hinting at hidden value for biotech‑savvy investors.

Insider buying at Palisade Bio shows executive confidence: Donald Allen’s 5,000‑share purchase amid modest volatility signals optimism for the GI therapy launch.